115
Views
2
CrossRef citations to date
0
Altmetric
Original Article

The protective effect of cilostazol on transverse rectus abdominis myocutaneous flap in rats

, , &
Pages 217-222 | Received 05 May 2016, Accepted 05 Sep 2016, Published online: 06 Oct 2016

References

  • Alderman AK, Wilkins EG, Kim HM, Lowery JC. Complications in postmastectomy breast reconstruction: two-year results of the Michigan breast reconstruction outcome study. Plast Reconstr Surg 2002;109:2265–74.
  • De Freitas AL, Gomes HC, Lisboa BC, et al. Effect of gene therapy with vascular endothelial growth factor after abdominoplasty on TRAM flap viability in a rat model. Plast Reconstr Surg 2010;125:1343–51.
  • McCraw JB, Horton CE, Grossman JA, et al. An early appraisal of the methods of tissue expansion and the transverse rectus abdominis musculocutaneous flap in reconstruction of the breast following mastectomy. Ann Plast Surg 1987;18:93–113.
  • Restifo RJ, Ahmed SS, Isenberg JS, Thomson JG. Timing, magnitude, and utility of surgical delay in the TRAM flap: I. Animal studies. Plast Reconstr Surg 1997;99:1211–16.
  • Tyner TR, Tong W, Donovan K, et al. Dichloroacetate reduces tissue necrosis in a rat transverse rectus abdominis musculocutaneous flap model. Ann Plast Surg 2006;56:320–6.
  • Clugston PA, Perry LC, Fisher J, Maxwell GP. A rat transverse rectus abdominis musculocutaneous flap model: effects of pharmacological manipulation. Ann Plast Surg 1995;34:154–61.
  • Dawson DL, Cutler BS, Meissner MH, Strandness DE. Jr. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 1998;98:678–86.
  • Burusapat C, Paengnoi J, Satayasoontorn K. An experimental study of the effect of pre-operative administration of cilostazol on random skin flap survival in rats: double blinded randomized controlled trial. Ann Surg Innov Res 2015;29:2–7.
  • Fuxian Z, Nishibe T, Yasuda K, et al. Effect of cilostazol on endothelial cell denudation and proliferation in canine vein grafts. Surg Today 2001;31:891–4.
  • Paige KT, Bostwick J, 3rd, Bried JT, Jones G. A comparison of morbidity from bilateral, unipedicled and unilateral, unipedicled TRAM flap breast reconstructions. Plast Reconstr Surg 1998;101:1819–27.
  • Dunn RM, Huff W, Mancoll J. The rat rectus abdominis myocutaneous flap: a true myocutaneous flap model. Ann Plast Surg 1993;31:352–7.
  • Doncatto LF, da Silva JB, da Silva VD, Martins PD. Cutaneous viability in a rat pedicled TRAM flap model. Plast Reconstr Surg 2007;119:1425–30.
  • Ely PB, Ferreira LM. Transverse rectus abdominis musculocutaneous flap (TRAM flap) in rat. Acta Cir Bras 2003;18:46–53.
  • Lee JH, Lee YK, Ishikawa M, et al. Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats-an MRI study. Brain Res 2003;994:91–8.
  • Nakamura T, Houchi H, Minami A, et al. Endothelium-dependent relaxation by cilostazol, a phosphodiesteras III inhibitor, on rat thoracic aorta. Life Sci 2001;69:1709–15.
  • Kim SH, Chang HW, Choi TH, et al. Cilostazol effectively reduces the decrease of flow volume in a thrombotic anastomosis model in a rat: a novel application of ultrasonography for evaluation. Ann Plast Surg 2010;64:482–6.
  • Fongs M, Yoshitake M, Kambayashi J, Liu Y. Cilostazol increases tissue blood flow in contracting rabbit gastrocnemius muscle. Circ J 2010;74:181–7.
  • Albuquerque RM, Virgini-Magalhaes CE, Bottino DA. Effect of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stres, and inflammatory markers in patients with intermittent claudication. Angiology 2008;59:549–58.
  • van den Heuvel MG, Buurman WA, Bast A, van der Hulst RR. Review: ischaemia-reperfusion injury in flap surgery. J Plast Reconstr Aesthet Surg 2009;62:721–6.
  • Park SY, Lee SW, Baek SH, et al. Induction of heme oxygenase-1 expression by cilostazol contributes to its anti-inflammatory effects in J774 murine macrophages. Immunol Lett 2011;136:138–45.
  • Omi H, Okayama N, Shimizu M, et al. Cilostazol inhibits high glucose-mediated endothelial-neutrophil adhesion by decreasing adhesion molecule expression via NO production. Microvasc Res 2004;68:119–25.
  • Iba T, Kidokoro A, Fukunaga M, et al. Comparison of the protective effects of type III Phosphodiesterase (PD3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in mice. Shock 2006;26:522–6.
  • Lee TM, Su SF, Tsai CH, et al. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication. Clin Sci (Lond) 2001;101:305–11.
  • Ono I, Gunji H, Suda K, Kaneko F. Effects of cilostazol lotion on blood flow in rabbit skin. J Dermatol Sci 1994;7:79–83.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.